QVT Financial LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
QVT Financial LP
CRD #156508
SEC #801-73049
CIK #0001290162
AUM 1,786.7 M (2026-03-31)
Employees 31 (26% Investors, 0% Brokers)
Fees
Minimum
Phone212-705-8888
Address888 Seventh Avenue
New York, NY 10106
Source [IAPD] [EDGAR] [Website]
Total AUM ($B)
151296302010201520212027
Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure]
FEES AND COMPENSATION

A. Advisory Services and Fees.

   Management Fees

   With respect to the Family Office Funds, investors are charged a monthly management
   fee, in arrears, based on the net asset value of the assets under management, typically at a
   rate of 1.75% per annum.

   With respect to the Fourth Avenue Funds, investors are not charged any management fee,
   unless specifically agreed.

   Incentive Allocation/Incentive Fees/Carried Interest

   Further, Clients structured as hedge funds also may be charged an annual incentive
   allocation/fee depending upon the investment mandate. Investors in the Private Funds
   (“Fund Investors”) that are withdrawing or redeeming other than at a fiscal year end will
   bear any incentive allocation/fee accrued at a date earlier than the year-end (i.e., through
   such withdrawal or redemption date).

   The incentive allocation for the Family Office Funds is (i) 17.5% for the master fund or
   intermediate fund, as the case may be; and (ii) 15% for side pockets, determined only on
   the basis of realized or partially realized side pocket investments.

   The respective offering documents and/or organizational documents will generally permit
   the Adviser or the Private Fund the ability to waive, rebate or reduce all or part of the
   management fee and/or performance compensation with respect to investments made by
   certain investors without waiving, rebating or reducing the management fee and/or
   performance compensation charged/payable to other investors (such as the case of, but
   not limited to, investments made by the Adviser, its Affiliates, its partners/employees and
   their family members in a Private Fund).

B. Payment of Fees.

   Fees and compensation paid to the Adviser or its Affiliates by the Private Funds are
   generally deducted from the assets of such Private Funds. As discussed above,
   management fees are generally deducted on a monthly or quarterly basis and performance
   compensation is generally deducted on an annual basis.

C. Additional Expenses and Fees.

   A Private Fund may bear operating and other expenses including, but not limited to, the
   following:

•   investment expenses, including without limitation, expenses that are related to the
    investment of the Private Fund’s assets, such as:

       o brokerage commissions and other costs of executing transactions,

       o investment-related travel expenses (which are travel expenses incurred by the
         Advisers related to the purchase, sale, transmittal or ongoing monitoring of
         the Private Fund’s investments),

       o interest expenses,

       o finance charges and clearing fees,

       o applicable withholding and other taxes,

       o consulting and other professional fees related to particular investments, and

       o legal, accounting, due diligence and other similar expenses attributable to
         investments (even if such investments are not consummated).

•   fees and expenses relating to software tools, programs or other technology utilized in
    managing the Private Funds, including, without limitation, technology to measure
    risk,

•   research and market data (including, without limitation, any computer hardware and
    telephone and data lines incorporated into the cost of obtaining such research and
    market data),

•   administrative expenses, including, without limitation,

       o the monthly service fees and expenses of an administrator,

       o paying agency, transfer agency, local representative, accounting verification
         (if any) and/or investor registrar services,

       o costs and expenses relating to the Private Fund’s regulatory compliance,
         including, without limitation, the costs of regulatory inquiries and regulatory
         filings, registrations and memberships,

•   legal expenses, such as

       o legal fees charged in negotiating prime brokerage, ISDA master agreements
         and related custody and segregation agreements, repurchase agreements or
         other trading or financing agreements,

       o the costs of revising the Private Fund’s offering and operative documents,

•   internal and external accounting and valuation expenses,

   •   audit and tax preparation and filing expenses, such as

           o tax advisory fees,

           o the costs of FATCA, OECD Common Reporting Standard and other tax-
             related compliance,

   •   insurance premiums (including, without limitation, Director and Officer liability
       and/or Errors & Omissions insurance, including for indemnified parties),

   •   custodial fees,

   •   entity-level taxes,

   •   organizational expenses,

   •   offering expenses (including, without limitation, costs associated with compliance
       with AIFMD and other local offering requirements),

   •   other expenses associated with the operation of such Private Fund, and

   •   extraordinary expenses.

D. Prepayment of Fees.

   Please see responses to 5A above.

E. Compensation for Sale of Securities or Other Investment Products.

   Neither the Adviser, its Affiliates, nor any of their supervised persons accept
   compensation for the sale of securities or other investment products.
Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure]
TYPES OF CLIENTS

The clients to whom the Adviser and its Affiliates provide investment management services and
advice are the Private Funds.

The offering documents of each Private Fund may set minimum amounts for investment by
prospective investors in such Private Funds. These minimum amounts may be waived by the
Adviser or an Affiliate, except to the extent prohibited by law.
Sector Form 13F Holdings Value ($B)
Roivant Sciences Ltd 0.7
Okeanis ECO Tankers Corp 0.1
Carvana Co 0.1
Goldman Sachs Group Inc 0.0
Allot Communications Ltd 0.0
Nelnet Inc 0.0
Nexstar Broadcasting Group Inc 0.0
New York Times Co 0.0
Nvidia Corp 0.0
Apple Inc 0.0
View All
Holdings by Sector ($B)
7.56.04.53.01.50.02011201620212027
Type Form D Funds Date Sold AUM
Other Fourth Avenue FF Opportunities LP - Series 11 2026-03-31 21.8 M
Other Fourth Avenue FF Opportunities LP - Series 12 2026-03-31 2.5 M
Other Fourth Avenue FF Opportunities LP - Series 13 2026-03-31 3.5 M
Other Fourth Avenue FF Opportunities LP - Series 14 2026-03-31 1.0 M
Other Fourth Avenue FF Opportunities LP - Series 15 2026-03-31 6.1 M
Other Fourth Avenue FF Opportunities LP - Series 16 2026-03-31 3.0 M
Other Fourth Avenue FF Opportunities LP - Series 17 2026-03-31 0.1 M
Other Fourth Avenue FF Opportunities LP - Series 18 2026-03-31 5.7 M
Other QVT Gilead Holdings LLC 2026-03-31 13.0 M
Other Fourth Avenue FF Opportunities LP - Series 10 2025-03-31 0.4 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 7 1.8
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 7 1.8
By Discretionary
Discretionary 7 1.8
Non-Discretionary 0 0.0
Total 7 1.8
By Non-United States Persons
Non-United States Persons 0.8
United States Persons 1.0
Total 7 1.8
Form D Directors Role # Filings # Firms 2011 - 2026
Ian Pilgrim Director 148 19
William Woods Director 23 6
W Woods Director 68 5
Daniel Gold Executive Officer 27 2
Arthur Chu Executive Officer 20 2
Nicholas Brumm Executive Officer 19 2
Tracy Fu Executive Officer 17 2
Qvt Associates GP LLC Executive Officer 8 2
Qvt Associates GP Executive Officer 5 2
Qvt Financial LP Executive Officer 4 2
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001290162]
3 [0001290162]
4 [0001290162]
SC 13D [0001290162]
SC 13G [0001290162]
Form 13D/13G Filer Form 13D/13G Subject Filed
QVT Financial LP Comtech Telecommunications Corp /DE/ [2026-05-15]
QVT Financial LP Tourmaline Bio Inc [2025-05-15]
QVT Financial LP AADI Bioscience Inc [2025-02-14]
QVT Financial LP Roivant Sciences Ltd [2022-02-14]
QVT Financial LP MP Materials Corp / de [2020-11-27]
QVT Financial LP Myovant Sciences Ltd [2019-06-14]
QVT Financial LP Grindrod Shipping Holdings Ltd [2018-11-05]
QVT Financial LP Urovant Sciences Ltd [2018-10-10]
QVT Financial LP Myovant Sciences Ltd [2017-02-10]
QVT Financial LP Agenus Inc [2017-02-03]
View All
Firm Profile (Form ADV)
Discretionary AUM$8.9B
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI549300JMMSS9C5S2HO30
Form 3/4/5 Subject 2011 - 2026
Roivant Sciences Ltd
QVT Financial LP
Okeanis Eco Tankers Corp
MP Materials Corp / DE
QVT Financial GP LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Roivant Sciences Ltd ROIV
Common Shares
2026-02-13 Sell 150,784 $26.49 3,994,268
Roivant Sciences Ltd ROIV
Common Shares
2026-02-13 Sell 225,000 $26.50 5,962,500
Roivant Sciences Ltd ROIV
Common Shares
2026-02-12 Sell 150,000 $26.72 4,008,000
Roivant Sciences Ltd ROIV
Common Shares
2026-02-12 Sell 275,000 $26.76 7,359,000
Roivant Sciences Ltd ROIV
Common Shares
2026-02-11 Sell 425,000 $26.67 11,334,750
Roivant Sciences Ltd ROIV
Common Shares
2025-12-17 Sell 432,718 $23.05 9,974,150
Roivant Sciences Ltd ROIV
Common Shares
2025-12-17 Sell 155,076 $23.02 3,569,850
Roivant Sciences Ltd ROIV
Common Shares
2025-12-17 Sell 189,538 $23.17 4,391,595
Roivant Sciences Ltd ROIV
Common Shares
2025-12-16 Sell 275,000 $22.93 6,305,750
Roivant Sciences Ltd ROIV
Common Shares
2025-12-16 Sell 642,282 $23.08 14,823,869
Roivant Sciences Ltd ROIV
Common Shares
2025-11-19 Sell 175,000 $20.24 3,542,000
Roivant Sciences Ltd ROIV
Common Shares
2025-11-19 Sell 150,000 $20.20 3,030,000
Roivant Sciences Ltd ROIV
Common Shares
2025-11-19 Sell 125,000 $20.16 2,520,000
Roivant Sciences Ltd ROIV
Common Shares
2025-11-19 Sell 850,000 $20.25 17,212,500
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 6,837,266 $0.00
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 6,205,368 $0.00
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 3,176,245 $0.00
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 19,311,790 $0.00
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 55,443 $0.00
Roivant Sciences Ltd ROIV
Common Shares
2025-06-25 Other 1,170,646 $0.00
showing 20 of 200 most recent transactions
Comparable Firms State AUM
D2 Asset Management LP
TX 1,825.9 M
ParaFi Capital LP
NY 1,817.8 M
Tensile Capital Management LP
CA 1,796.0 M
Morgan Creek Capital Management LLC
NC 1,790.2 M
Alta Park Capital LP
CA 1,779.6 M
Great Point Partners LLC
CT 1,777.1 M
OFS Capital Management LLC
IL 1,760.0 M
RCF Management LLC
CO 1,757.0 M
Parkman Healthcare Partners LLC
CT 1,744.0 M
Long Path Partners LP
CT 1,732.8 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com